• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Immuron Ltd ADR (NQ: IMRN )

    2.795 +0.075 (+2.76%)
    Streaming Delayed Price Updated: 3:47 PM EDT, Oct 1, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 14,162
    Open 2.710
    Bid (Size) 2.550 (2)
    Ask (Size) 3.350 (15)
    Prev. Close 2.720
    Today's Range 2.665 - 2.867
    52wk Range 1.481 - 5.960
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Immuron Plans Phase 2 Trial for IMM-529 following FDA review
    From Immuron Limited
    Via GlobeNewswire
    Immuron Announces New U.S. Department of Defense Research Award for Naval Medical Research Command and Walter Reed Army Institute of Research to advance Travelan®
    From Immuron Limited
    Via GlobeNewswire

    Performance

    YTD
    +47.11%
    +47.11%
    1 Month
    +4.92%
    +4.92%
    3 Month
    +29.34%
    +29.34%
    6 Month
    +3.52%
    +3.52%
    1 Year
    +49.46%
    +49.46%

    More News

    Read More
    Immuron CEO, Steven Lydeamore to present at the Emerging Growth Conference
    From Immuron Limited
    Via GlobeNewswire
    Immuron CEO, Steven Lydeamore to host webinar on MarketOpen Direct Connect
    From Immuron Limited
    Via GlobeNewswire
    Immuron announces record Travelan® sales globally, Australia and USA
    From Immuron Limited
    Via GlobeNewswire
    Immuron requests pre-IND meeting for IMM-529 with FDA filing
    From Immuron Limited
    Via GlobeNewswire
    Immuron CEO, Steven Lydeamore to present at the Emerging Growth Conference
    From Immuron Limited
    Via GlobeNewswire
    Immuron Board Changes
    From Immuron Limited
    Via GlobeNewswire
    Immuron CEO Steven Lydeamore to present at Peak Sky High
    From Immuron Limited
    Via GlobeNewswire
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    Immuron Limited to Present at the Emerging Growth Conference
    From Immuron Limited
    Via GlobeNewswire
    Immuron Director Resignation
    From Immuron Limited
    Via GlobeNewswire
    Immuron to host Live Virtual Event
    From Immuron Limited
    Via GlobeNewswire
    Why Ascent Solar Technologies Shares Are Trading Lower By Around 50%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    Why PriceSmart Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Immuron Travelan® sales continued strong growth
    From Immuron Limited
    Via GlobeNewswire
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    Why Mesoblast Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    Exposures Product Safety
    Why Fangdd Network Group Shares Are Trading Higher By Around 78%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Why Marvell Technology Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Intraday Session
    Via Benzinga
    Why Porch Group Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.